Is Lymphoma Curable: Knowing The Sub-Type Is Key

It's very common for people recently diagnosed with a subtype of lymphoma to want to know if Non-Hodgkin's Lymphoma is curable. Unfortunately the answer is not as simple as this. In order to have some idea about whether or not lymphoma is curable, one must know the subtype.

"Lymphoma" is a blanket term for several dozen types of lymphoma cancer, each of which is different with differing prognoses. To that end, we'll take a brief look at some of the more frequently diagnosed lymphomas and examine their known prognoses.

Is Diffuse Large B-Cell Lymphoma Curable?

This moderately aggressive non-Hodgkin lymphoma is the most frequently diagnosed lymphoma subtype. It has therefore enjoyed a lot of attention from the research community, and one can safely estimate that approximately 50% of patients are curable—whether that means with first-line therapy or last-line therapy, such as a stem cell transplant.

Is Follicular Lymphoma Curable?

This non-Hodgkin lymphoma is typically diagnosed in people over the age of 50, and it is often not found until the disease is in its later stages. Follicular lymphoma (FL) is not considered a curable cancer, chiefly because it is considered an indolent, or non-aggressive, cancer. However, 'incurable' should not be mistaken in this instance for 'fatal', as most patients with FL will not die from their lymphoma. It is considered a manageable disease, so often patients will endure some form of therapy, then go from months to years without any therapy or symptoms, then take up some form of therapy again when necessary.

Is Hodgkin's Lymphoma Curable?

Hodgkin lymphoma (HL), also known as Hodgkin's disease, is a very rare type of lymphoma that affects about 10,000 people in the United States each year. A tremendous amount of research has gone into Hodgkin's lymphoma over the past 50 years, and the consequence is that HL has become one of the more curable cancers, with a cure rate that can approach 90% depending on various factors. While HL patients enjoy high cure rates, sometimes HL proves refractory, meaning it does not respond to treatment. While this is not common, it nonetheless does occur.

Related Reading

Photo: Pixabay

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap